307 related articles for article (PubMed ID: 29900639)
1. Neuroprotection in glaucoma: recent advances and clinical translation.
Guymer C; Wood JP; Chidlow G; Casson RJ
Clin Exp Ophthalmol; 2019 Jan; 47(1):88-105. PubMed ID: 29900639
[TBL] [Abstract][Full Text] [Related]
2. Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma.
De Moraes CG; Liebmann JM; Levin LA
Prog Retin Eye Res; 2017 Jan; 56():107-147. PubMed ID: 27773767
[TBL] [Abstract][Full Text] [Related]
3. Bio-tactics for neuroprotection of retinal ganglion cells in the treatment of glaucoma.
Yadav KS; Sharma S; Londhe VY
Life Sci; 2020 Feb; 243():117303. PubMed ID: 31953158
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Strategies in Glaucoma.
Gossman CA; Christie J; Webster MK; Linn DM; Linn CL
Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878
[TBL] [Abstract][Full Text] [Related]
5. Disease progression and the need for neuroprotection in glaucoma management.
Varma R; Peeples P; Walt JG; Bramley TJ
Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
[TBL] [Abstract][Full Text] [Related]
6. A review of potential novel glaucoma therapeutic options independent of intraocular pressure.
Shalaby WS; Ahmed OM; Waisbourd M; Katz LJ
Surv Ophthalmol; 2022; 67(4):1062-1080. PubMed ID: 34890600
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective agents in the management of glaucoma.
Nucci C; Martucci A; Giannini C; Morrone LA; Bagetta G; Mancino R
Eye (Lond); 2018 May; 32(5):938-945. PubMed ID: 29472700
[TBL] [Abstract][Full Text] [Related]
8. The potential of neuroprotection in glaucoma treatment.
Osborne NN; Chidlow G; Nash MS; Wood JP
Curr Opin Ophthalmol; 1999 Apr; 10(2):82-92. PubMed ID: 10537768
[TBL] [Abstract][Full Text] [Related]
9. Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement.
Chang EE; Goldberg JL
Ophthalmology; 2012 May; 119(5):979-86. PubMed ID: 22349567
[TBL] [Abstract][Full Text] [Related]
10. New perspectives on target intraocular pressure.
Clement CI; Bhartiya S; Shaarawy T
Surv Ophthalmol; 2014; 59(6):615-26. PubMed ID: 25081325
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection in glaucoma.
Vishwaraj CR; Kavitha S; Venkatesh R; Shukla AG; Chandran P; Tripathi S
Indian J Ophthalmol; 2022 Feb; 70(2):380-385. PubMed ID: 35086201
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection in glaucoma--delusion, reality or hope?
Dimovska-Jordanova A
Prilozi; 2012; 33(2):163-73. PubMed ID: 23425879
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection in the treatment of glaucoma--A focus on connexin43 gap junction channel blockers.
Chen YS; Green CR; Danesh-Meyer HV; Rupenthal ID
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):182-93. PubMed ID: 25676338
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of the endothelin A (ET
McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
[TBL] [Abstract][Full Text] [Related]
15. Is neuroprotection a viable therapy for glaucoma?
Weinreb RN; Levin LA
Arch Ophthalmol; 1999 Nov; 117(11):1540-4. PubMed ID: 10565524
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection for glaucoma: Requirements for clinical translation.
Levin LA; Crowe ME; Quigley HA;
Exp Eye Res; 2017 Apr; 157():34-37. PubMed ID: 27955999
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel inhibitors for the treatment of glaucoma.
Cholkar K; Trinh HM; Pal D; Mitra AK
Expert Opin Drug Discov; 2015 Mar; 10(3):293-313. PubMed ID: 25575654
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
Osborne NN; Ugarte M; Chao M; Chidlow G; Bae JH; Wood JP; Nash MS
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S102-28. PubMed ID: 10416754
[TBL] [Abstract][Full Text] [Related]
19. Review of rodent hypertensive glaucoma models.
Biswas S; Wan KH
Acta Ophthalmol; 2019 May; 97(3):e331-e340. PubMed ID: 30549197
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection in glaucoma: recent and future directions.
Danesh-Meyer HV
Curr Opin Ophthalmol; 2011 Mar; 22(2):78-86. PubMed ID: 21252670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
